Toward peptide-based inhibitors as therapies for Parkinson's disease.
Department of Biology & Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Jody M
JM
Mason
Division of Chemistry & Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
David P
DP
Fairlie
D006801:Humans; D020734:Parkinsonian Disorders / Q000188:drug therapy* / Q000378:metabolism; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D051844:alpha-Synuclein / Q000037:antagonists & inhibitors* / Q000378:metabolism
D010455:Peptides; D051844:alpha-Synuclein
Parkinson's disease; amyloid; drug design; mimetics; peptides; α-synuclein